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a  b  s  t  r  a  c  t
INTRODUCTION:  Symptomatic  chronic  mesenteric  ischemia  (CMI)  is  an  uncommon  condition  that  usually
presents  with  intestinal  angina,  sitophobia  and  unintentional  weight  loss.  Acute  acalculous  cholecystitis
(AAC)  has  very  rarely  been  described  in  the  settings  of  CMI.
PRESENTATION  OF  CASE:  We  describe  a case  of  a 73  year  old  man  that  developed  an  AAC as  a complication
of  CMI.  The  patient  underwent  a simultaneous  cholecystectomy  and  open  aortic  revascularization  which
was  successful.  At  24  months  of  follow-up  the patient  is clinically  well  and  regained  weight.
DISCUSSION:  Ischemia  has  been  considered  an  important  etiology  for the  development  of  AAC. In  the
settings of  CMI,  an  AAC  might  develop  has  a herald  sign  of progression  to  acute  mesenteric  ischemiacute acalculous cholecystitis
pen aortic revascularization
ase report
and  infarction,  as  the  cystic  artery  is  a terminal  artery  with  no  collateral  network.  Performing  the aortic
revascularization  simultaneously  with  the  cholecystectomy  might  prevent  this  possible  fatal  outcome.
CONCLUSION:  This  case  reinforces  aortic  and  visceral  occlusive  disease  as  a possible  risk  factor  for  the
development  of AAC,  and discusses  the  treatment  controversies  when  managing  both  conditions  simul-
taneously.
 Publi
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. Introduction
Chronic Mesenteric Ischemia (CMI) is an uncommon condition
hat is being diagnosed more frequently as the use of imaging tests
s CTA became more widesspread [1]. Symptoms usually appear
hen at least two of the three main aortic visceral arteries are
ccluded [2], and in symptomatic patients treatment is required
ecause of a greater risk of bowel infarction [3]. Symptoms of
MI  usually include intestinal angina, sitophobia, and unintentional
eight loss [4]. Cholecystitis is very rarely described in the settings
f CMI  [5,6].
We  describe a case of an acute acalculous cholecystitis (AAC)
hich developed in the context of CMI  and discuss its management.
. Presentation of caseA 73 year old male was referred to our Vascular Surgery Depart-
ent with a diagnosis of CMI. The patient had been complaining of
ncreasing abdominal epigastric pain over the previous 3 months.
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The pain was continuous and persistent but worsened severely
after eating and was associated with anorexia and weight loss
(20 kgs). He also complained of constipation alternating with diar-
rhoea and 3 episodes of postprandial vomiting with some relief
of the epigastric pain. The patient had a history of hypertension,
chronic alcohol consumption (125 g/day), previous smoking habits
(stopped 25 years ago), and bilateral lower limb intermittent clau-
dication, accompanied by paraesthesia of the right foot for the
last 6 months, when walking. His regular medication included
pentoxyﬁlline and telmisartan plus hydrochlorotyazide. On admis-
sion, the patient presented with mild epigastric tenderness, weak
femoral pulses and absent popliteal, posterior tibial and dorsalis
pedis pulses bilaterally.
An abdominal and pelvic CT angiography (CTA) showed dif-
fuse aortic atheromatosis with extensive aortoiliac calciﬁcations,
preocclusive celiac trunk stenosis with distal vessels patent, a
2 cm occlusion from the origin of the superior mesenteric artery
(SMA), occlusion of the inferior mesenteric artery, left common iliac
artery stenosis and occlusion of the right superﬁcial femoral artery.
(Fig. 1). The patient was scheduled for elective revascularization.
On the 4th day after admission, he referred worsening of
his abdominal pain associated with right hypochondrial pain
and a positive Murphy’s sign, followed by fever, leukocytosis,
raised C reactive protein (22,5 mg/dL); aspartate aminotransferase
(53 iU/L); alanine transaminase (99 iU/L) and gamma-glutamyl
roup Ltd. This is an open access article under the CC BY-NC-ND license (http://
CASE  REPORT  –  OPEN  ACCESS
208 R. Melo et al. / International Journal of Surgery Case Reports 25 (2016) 207–211
Fig. 1. Pre operative 3D contrast-enhaced CT angiography: lateral view of aorta and origin of visceral vessels, showing preocclusive celiac trunk stenosis and occlusion of the
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crigin  and initial 2 cm of the SMA  (A). Pre operative contrast-enhaced CT angiograp
runk  (C); lateral view of the origin of the SMA  (D); cross view of the origin of the S
ranspeptidase (295 iU/L). An abdominal ultrasound showed an
nlarged gallbladder, with wall thickening and peri-vesicular ﬂuid
ith no visible calculi, leading to the diagnosis of AAC. The patient
as started on piperacillin plus tazobactam.
As there was no improvement over the next 24 h, the patient
nderwent median laparotomy which conﬁrmed the acute chole-
ystitis but revealed no loss of integrity of the gallbladder wall or
igns of peritonitis. A cholecystectomy was performed, followed
y a simultaneous revascularization procedure for treatment of
is extensive aortic and visceral occlusive disease. Due to the
xhuberant calciﬁcation of the visceral aorta, precluding infrarenal
lamping and anastomosis, a bypass to the common femoral
rteries had to be performed from the supraceliac aorta (using
 16 × 8 mm Dacron graft) which was tunnelled through the
etro-pancreatic area. Visceral revascularization was  achieved by
etrograde bypasses from the aorto-bifemoral graft to the SMA  and
o the common hepatic artery (using 8 mm Dacron grafts). (Fig. 2A)
fter declamping, an area of bowel infarction was recognized in
he ileum, requiring a 25 cm small bowel resection and intesti-
al continuity ensured through mechanical latero-lateral enteric
nastomosis. (Fig. 3).
The immediate post-op was uneventful except for a biliary ﬁs-
ula secondary to a cystic stump dehiscence which was resolved
y endoscopic sphincterotomy and placement of a prosthesis in
he common bile duct. The patient was discharged on the 17th day
fter surgery.
The post-operative CT angiography showed good patency
esults with no surgical complications (Fig. 2B). The patient
egained weight and is clinically well 24 months after surgery.. Discussion
AAC is a rare condition, representing only 10% of all acute chole-
ystitis and usually appears in critically ill patients, as in the contextteral view of the origin of the celiac trunk (B); cross view of the origin of the celiac
).
of trauma, shock, sepsis and major burns and is associated with a
high complication and mortality rate [7]. In the setting of CMI, AAC
has seldom been reported in the past as the most common compli-
cation of CMI  is acute mesenteric ischemia and bowell infarction
[1]. Savoca et al. reported two cases where AAC secondary to
mesenteric graft occlusion developed in patients who had been
treated for CMI  [6], and Koea et al. reported a case of AAC in a patient
who was later found to have CMI  [5]. Although extremely rare, in
a seven year study on AAC, Savoca et al. found that 72% of outpa-
tients who  developed AAC had clinically signiﬁcant atherosclerotic
vascular disease with no other major conditions to predispose to
AAC, which may  reinforce aortic atherosclerosis as a risk factor for
the development of AAC [8].
Therefore, although AAC has been associated with critically ill
patients, recent reports show that AAC can present de novo in an
outpatient setting without any major illness or associated trauma
[8–10], and aortic occlusive disease may  represent the most rele-
vant etiological factor in these patients [8].
Currently, AAC is considered to be a multifactorial process, in
which bile stasis and ischemia play a major role [7]. Ischemic injury
is crucial in the pathogenesis of AAC because the cystic artery is ter-
minal, making the gallbladder susceptible to low-ﬂow states [11].
Furthermore, Hakala et al. reinforced the importance of microcircu-
latory disturbances in the pathogenesis of AAC [10] and Warren has
shown that in contrast to calculus cholecystitis, in AAC, gallbladders
show “multiple arterial occlusions with absent or minimal venous
ﬁlling” [12].
AAC has also been described in a few case reports occurring just
before the development of mesenteric infarction in the context of
acute mesenteric ischemia [13–15]. In all of these cases, the AAC
was thought to be a herald sign of critical ischemia and mesen-
teric infarction, which resulted in death in two  of these case reports
[14,15].
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Fig. 2. Aortic revascularization using Dacron grafts showing the supraceliac to bifemoral bypass and retrograde hepatic and superior mesenteric bypasses from the aortob-
ifemoral graft (A). Post operative 3D contrast-enhaced CT angiography showing good patency results (B).
). Pos
a
cFig. 3. Area of bowel infarction in the ileum (A) and (B
In our case, the AAC might have developed in the same fashion
s a consequence of an acute-on-chronic mesenteric ischemia.
AAC management usually includes broad-spectrum antibiotics
overing enteric organisms, cholecystectomy and/or cholecys-t resection mechanical latero-lateral anastomosis (C).
tostomy when the patient is critically ill [16]. In this case, because
the AAC developed in the context of CMI, a cholecystectomy was
indicated [7], raising several questions regarding visceral revascu-
larization, its modality and timing for its performance.
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Endovascular mesenteric revascularization has a recognised
ower peri-operative morbidity and mortality rate, being particu-
arly appropriate for limited occlusive lesions [1,3]. However, in
ases of symptomatic, diffuse aorto-iliac occlusive disease with
xhuberant calciﬁcation of the involved arteries its long-term dura-
ility and patency are less favourable when compared with open
urgical reconstruction which, in such a setting should be consid-
red the procedure of choice [1,3]. The use of prosthetic grafts for
hese reconstructions, in a potentially infected territory, following
holecystectomy or bowel resection, has a necessarily higher risk of
raft infection. However autologous conducts are rarely available
or such extensive aorto-iliac reconstruction. The use of deep veins
uch as described in the Neoaortoiliac System (NAIS) procedure,
lthough feasible, is a very extensive and complex procedure usu-
lly not adequate if an urgent revascularization is to be performed
n an acutely ill patient [17].
Antibiotic-bonded and antiseptic-impregnated grafts and cry-
preserved allografts have been used not only as a preventive
echnique to avoid future infections but also for in situ replacement
or infected grafts [18–21]. However, these grafts, are not widely
ccessible in our institution for urgent settings, and the literature
as not shown a clear advantage over non antibiotic/antiseptic
oated grafts in potentially infected territories [18,19].
The risk of graft bacterial contamination can be minimized by
areful, adequate and meticulous surgical technique [21].
In our case, we used the retro-pancreatic area for tunnelization
f the main body of the bifurcated graft, in order to try to reduce the
isk of direct contact of the prosthetic material with the bowel and
he potentially infected territory. To date and to our knowledge, this
echnique has not been clearly described in the literature for this
urpose and our decision was empirical, in an emergent setting.
Considering the treatment strategy and timing of the proce-
ures, as a cholecystectomy was mandatory, the solution to reduce
he risk of graft infection deferred visceral revascularization within
 two stage operation could be enviseaged. However, if AAC would
e considered as a manifestation of visceral ischemia secondary
o reduced critical mesenteric perfusion, a higher risk for the
evelopment of bowel infarction must be considered, as reported
reviously [13,14] Therefore, the decision was taken to proceed
ith immediate mesenteric revascularization in order to minimize
he risk and extension of a possible bowel infarct.
The post-operative period was complicated by a biliary ﬁstula
reated by endoluminal sphincterotomy without evidence of overt
eritonitis or signs of graft infection.
The patient has been well, regained weight, is fully asymp-
omatic without any clinical or laboratorial evidence suggesting
ny infectious complication at a follow-up of 24 months.
. Conclusion
This case reinforces the importance of visceral ischemia as a risk
actor of AAC, which can be a possible complication in CMI  patients
nd a marker of severe critical visceral ischemia and a higher risk
f progression to acute mesenteric infarction.
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